Deutsche Bank Ag\ Glycomimetics Inc Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$2.16 - $3.18 $76,086 - $112,015	-35,225 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$2.89 - $4.22 $947 - $1,384	-328 Reduced 0.92%	35,225 $106,000
Q4 2020 Feb 16, 2021	BUY	$2.69 - $4.24 $45,364 - $71,503	16,864 Added 90.23%	35,553 $133,000
Q3 2020 Nov 12, 2020	BUY	$3.07 - $5.0 $6,793 - $11,065	2,213 Added 13.43%	18,689 $58,000
Q2 2020 Aug 13, 2020	BUY	$2.06 - $3.76 $10,304 - $18,807	5,002 Added 43.59%	16,476 $62,000
Q1 2020 May 14, 2020	SELL	$1.83 - $5.41 $1,259 - $3,722	-688 Reduced 5.66%	11,474 $26,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $6.5 $10,929 - $17,628	2,712 Added 28.7%	12,162 $63,000
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $21,378 - $98,109	-7,635 Reduced 44.69%	9,450 $40,000
Q2 2019 Aug 14, 2019	SELL	$10.6 - $13.12 $45,654 - $56,507	-4,307 Reduced 20.13%	17,085 $201,000
Q1 2019 May 15, 2019	SELL	$9.96 - $13.44 $459,893 - $620,578	-46,174 Reduced 68.34%	21,392 $265,000
Q4 2018 Feb 14, 2019	SELL	$8.47 - $14.71 $758,327 - $1.32 Million	-89,531 Reduced 56.99%	67,566 $639,000
Q3 2018 Dec 21, 2021	BUY	$13.7 - $17.12 $1.15 Million - $1.43 Million	83,613 Added 113.78%	157,097 $2.26 Million
Q3 2018 Nov 14, 2018	SELL	$13.7 - $17.12 $694,576 - $867,966	-50,699 Reduced 40.83%	73,484 $1.06 Million
Q2 2018 Apr 21, 2020	BUY	$14.63 - $19.19 $261,277 - $342,714	17,859 Added 16.8%	124,183 $2 Million
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.19 $483,609 - $634,344	-33,056 Reduced 23.72%	106,324 $1.71 Million
Q1 2018 Oct 18, 2019	BUY	$16.06 - $25.35 $1.46 Million - $2.31 Million	91,059 Added 188.45%	139,380 $2.26 Million
Q1 2018 May 15, 2018	SELL	$16.06 - $25.35 $1.39 Million - $2.19 Million	-86,530 Reduced 64.17%	48,321 $783,000
Q4 2017 Feb 14, 2018	SELL	$10.51 - $17.22 $1.31 Million - $2.15 Million	-124,938 Reduced 48.09%	134,851 $2.26 Million
Q3 2017 Nov 14, 2017	BUY	$10.14 - $14.85 $2.63 Million - $3.86 Million	259,789	259,789 $3.63 Million

Others Institutions Holding GLYC

# of Institutions

Shares Held

25.6M

Call Options Held

1.94M

Put Options Held

153K

Bvf Inc San Francisco, CA

9.54M
Shares

$1.62 Million
0.08% of portfolio
Artal Group S.A. Luxembourg, N4

8.59M
Shares

$1.46 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

2.7M
Shares

$458,474
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

827K
Shares

$140,564
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

804K
Shares

$136,738
0.0% of portfolio

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $8.91M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account